Back to AVTX

TCG Crossover Management, LLC → AVTX

TCG Crossover Management, LLC AVTX Position History

Avalo Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$46.3M
Q3 2026
Peak value
$55.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$8.8M
Q1 2026$11M
Q2 2026$55.8M
Q3 2026$46.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$46.3M3.02M——
Q2 2026$55.8M3.02M——
Q1 2026$11M738.4K——
Q4 2025$8.8M483.0K——

Other funds holding AVTX

Other TCG Crossover Management, LLC positions

AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$959M
AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$800.6M
AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$721.7M
AAVXF

ABIVAX SA AMERICAN DEPOSITARY SHARES

$362.7M
TNGX

TANGO THERAPEUTICS INC

$283.9M
CGON

CG ONCOLOGY INC

$260.8M
CGON

CG ONCOLOGY INC

$260.2M
CGON

CG ONCOLOGY INC

$248.4M